Behavioral
Weight gain
Weight gain is a behavioral intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed133%
recruiting133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
NCT02573753
completednot_applicable
The GlasVEGAS Study (Glasgow Visceral & Ectopic Fat With Weight Gain in South AsianS)
NCT02399423
unknown
Weight Change and the Risk of Chronic Pain Following Hip and Knee Arthroplasties
NCT06024161
Clinical Trials (3)
Showing 3 of 3 trials
NCT02573753Not Applicable
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
NCT02399423Not Applicable
The GlasVEGAS Study (Glasgow Visceral & Ectopic Fat With Weight Gain in South AsianS)
NCT06024161
Weight Change and the Risk of Chronic Pain Following Hip and Knee Arthroplasties
All 3 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 3